Recursion Pharmaceuticals【RXRX】株式ニュース

名称	銘柄コード	市場	種別
Recursion Pharmaceuticals Inc	RXRX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.27	-2.86%	9.17	13:00:08

始値	安値	高値	終値	前日終値
9.24	9.165	9.41	9.26	9.44

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/15	06:12	EDGAR2	Form 144/A - Report of proposed sale of securities: [Amend]
2024/6/15	05:29	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/14	06:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/14	05:10	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/12	05:13	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/08	05:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/07	22:00	EDGAR2	Form 8-K - Current report
2024/6/06	23:36	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/06	07:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	07:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	07:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	07:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	01:30	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/04	07:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/03	22:00	GLOBE	Recursion to Participate in Upcoming Investor Conferences
2024/5/31	07:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/31	05:03	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/30	04:27	GLOBE	Power of Recursion OS on Display at Genome Scale in Nature..
2024/5/25	05:35	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2024/5/25	05:31	EDGAR2	Form 8-K - Current report
2024/5/25	05:30	GLOBE	Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair..
2024/5/18	08:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	08:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	08:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	08:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/17	05:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/15	05:25	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/13	18:00	GLOBE	Recursion Announces Completion of NVIDIA-Powered BioHive-2,..
2024/5/10	05:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/10	05:01	GLOBE	Recursion Provides Business Updates and Reports First..
2024/5/02	21:00	GLOBE	Recursion to Report First Quarter 2024 Business Updates and..
2024/5/01	21:01	GLOBE	Recursion to Participate in Upcoming Investor Conferences
2024/4/30	21:00	GLOBE	Altitude Lab Secures Small Business Administration Growth..
2024/4/16	21:00	GLOBE	Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and..
2024/4/02	21:00	GLOBE	Recursion to Participate in Upcoming Investor Conference
2024/3/26	21:00	GLOBE	Recursion Publishes Annual Environmental, Social and..
2024/3/11	17:00	GLOBE	Recursion Announces Plans to Open New Office in London
2024/3/09	09:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/08	08:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	07:39	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/07	06:59	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/06	06:18	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/02	04:58	GLOBE	Recursion Hosts Second Annual Rare Disease Day Events for..
2024/3/01	21:59	GLOBE	Recursion to Participate in Upcoming Investor Conferences
2024/2/29	22:25	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/28	06:05	GLOBE	Recursion Provides Business Updates and Reports Fourth..
2024/2/24	09:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/23	08:13	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/22	07:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/21	06:29	EDGAR2	Form 144 - Report of proposed sale of securities